InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (53 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
53
T+90 hit rate
0%
T+90 mean return
-24.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Payson Norman, Board Member. Director active across 1 company, notably Progyny, Inc.. Cumulatively, 62 reports have been logged. Split: 0 buy · 53 sells. Total volume traded: €9.9m. Activity tracked since 22 July 2021. The latest transaction was filed on 14 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations62 total
36,224 shares@ US$1.450.4% of flowCommon StockSEC:0001551306-25-000199:0
6,689 shares0Common StockSEC:0001551306-25-000110:0
6,176 shares0Common StockSEC:0001551306-24-000118:0
4,385 shares0Common StockSEC:0001628280-23-019980:0
8,652 shares0Common StockSEC:0001628280-23-004045:0
6,617 shares@ US$30.891.2% of flowCommon StockSEC:0001628280-22-032590:0
6,617 shares@ US$31.651.2% of flowCommon StockSEC:0001628280-22-032493:0
2,300 shares@ US$30.080.4% of flowCommon StockSEC:0001628280-22-031664:0
6,617 shares@ US$34.251.3% of flowCommon StockSEC:0001628280-22-030871:0
6,617 shares@ US$33.801.3% of flowCommon StockSEC:0001628280-22-030749:0
4,417 shares@ US$37.541.0% of flowCommon StockSEC:0001628280-22-029821:0
3,884 shares@ US$41.081.0% of flowCommon StockSEC:0001628280-22-027321:0
3,480 shares0Common StockSEC:0001628280-22-027107:0
6,217 shares@ US$38.351.5% of flowCommon StockSEC:0001628280-22-026414:0
1,900 shares@ US$38.540.5% of flowCommon StockSEC:0001628280-22-025809:0
6,618 shares@ US$41.711.7% of flowCommon StockSEC:0001628280-22-025072:0
6,618 shares@ US$40.331.6% of flowCommon StockSEC:0001628280-22-024279:0
6,518 shares@ US$43.671.7% of flowCommon StockSEC:0001628280-22-023338:0
1,785 shares@ US$31.820.3% of flowCommon StockSEC:0001551306-22-000019:0
6,618 shares@ US$33.401.3% of flowCommon StockSEC:0001415889-22-007910:0
5,220 shares@ US$29.260.9% of flowCommon StockSEC:0001415889-22-007584:0
6,618 shares@ US$27.350.0077% mcap1.3% of flowCommon StockSEC:0001415889-22-006915:0
6,618 shares@ US$30.370.0085% mcap1.4% of flowCommon StockSEC:0001415889-22-006415:0
6,018 shares@ US$32.030.0081% mcap1.3% of flowCommon StockSEC:0001415889-22-005867:0
5,518 shares@ US$33.300.0079% mcap1.3% of flowCommon StockSEC:0001415889-22-004958:0
25 of 62 declarations
About Payson Norman
Norman Payson, M.D. has served on the board of directors of Progyny, Inc. since December 2016. The company says he co-founded Healthsource and was its chief executive officer from 1985 to 1997, served as chief executive officer of Oxford Health Plans from 1998 to 2002, chairman of Concentra from 2005 to 2008, and chief executive officer of Apria Healthcare Group from 2008 to 2012. Progyny also says he has been president and a director of NCP, Inc., his family office, since 1997, and that he holds a B.S. from MIT and an M.D. from Dartmouth Medical School. Sources: https://investors.progyny.com/board-member/norm-payson/
